Microbot Medical Inc (MBOT)

$2.42 -0.05 (-2.02%)
Market Cap 162.52M
Revenue (ttm) 0.00
Net Income (ttm) -11.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,712,700
Avg Vol 4,933,550
Day's Range N/A - N/A
Shares Out 67.16M
Stochastic %K 5%
Beta 1.25
Analysts Sell
Price Target $12.00

Company Profile

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides No...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 781-875-3605
Address:
175 Derby Street, Bld. 27, Hingham, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 5:24 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $MBOT Current Share Price: $2.42 Contracts: $MBOT January 15, 2027 $2 Calls Scale in: $0.98- $1.20 Scale out: $1.52-$1.96 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 2:15 PM
Enter: $MBOT Calls Strike Price: $2 Expiry Date: NOV 21 2025 Buy in Price: $0.30 - $0.40 Sell Price: $0.53 Profit : +75% (Turn every $1 into $1.75) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
Djmorri
Djmorri Oct. 25 at 10:46 AM
$MBOT . Remember, the 12$ pt is the opinion of 1 analyst..only revenue will instill confidence now after the dilution pollution immediately upon fda approval
0 · Reply
aerts2js
aerts2js Oct. 25 at 12:07 AM
$MBOT We are now lower compared to where we were PRIOR to FDA approval. It’s very disappointing. I think we are cooked.
5 · Reply
Reddyrob
Reddyrob Oct. 24 at 9:13 PM
$MBOT by december we will come to know which one MBOT is Good product with good management Or Good product with a bad management Or Bad product with a bad management Or Bad product with a good management. Till then im Bearish
1 · Reply
Daquanladariusblackman2
Daquanladariusblackman2 Oct. 24 at 9:07 PM
$MBOT 100% chance your brain is the size of an amoeba.
0 · Reply
Eddypgil
Eddypgil Oct. 24 at 9:00 PM
$MBOT 50 50 chance it does a reverse split in next two years
0 · Reply
Reddyrob
Reddyrob Oct. 24 at 8:54 PM
$MBOT this company is nowehere where RR is and never will be. RR solves a real world problem of staff shortage and high wage. $MBOT Is in safety business. Both are different vericals. Im sure this product will sell if marketed well. Many of us here only because of FDA, medical devices is not easy to sell first of all. But once customers started using it and ok with it, it cannot be replaced. This stock will fly when sales and customer reviews or results pops everywhere. Im in here with heavy investment and ready to invest more at sub 2 level/by December/at 52wk high. Till then just watch.
0 · Reply
godmode426
godmode426 Oct. 24 at 8:25 PM
$MBOT This company is shady, look at all the names it went through previously and they dilute shares constantly. Never invest in Israel.
2 · Reply
richestbear
richestbear Oct. 24 at 8:11 PM
$MBOT bro…. Sad POS 💩
0 · Reply
Latest News on MBOT
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

Oct 16, 2025, 8:30 AM EDT - 9 days ago

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

Oct 14, 2025, 8:30 AM EDT - 11 days ago

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Oct 7, 2025, 8:00 AM EDT - 18 days ago

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Oct 1, 2025, 9:00 AM EDT - 24 days ago

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

Sep 23, 2025, 8:30 AM EDT - 4 weeks ago

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Sep 16, 2025, 3:37 PM EDT - 5 weeks ago

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

Sep 15, 2025, 8:00 AM EDT - 5 weeks ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Sep 9, 2025, 8:28 AM EDT - 6 weeks ago

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Sep 8, 2025, 8:28 AM EDT - 6 weeks ago

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst

Aug 28, 2025, 3:57 PM EDT - 2 months ago

Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Aug 20, 2025, 8:30 AM EDT - 2 months ago

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Aug 5, 2025, 8:30 AM EDT - 2 months ago

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Jul 22, 2025, 8:30 AM EDT - 3 months ago

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Jul 8, 2025, 8:30 AM EDT - 3 months ago

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Microbot Medical® Added to the Russell Microcap® Index

Jun 30, 2025, 8:30 AM EDT - 4 months ago

Microbot Medical® Added to the Russell Microcap® Index

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Jun 17, 2025, 8:30 AM EDT - 4 months ago

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Jun 9, 2025, 8:30 AM EDT - 4 months ago

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Jun 5, 2025, 8:30 AM EDT - 5 months ago

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Apr 23, 2025, 8:30 AM EDT - 6 months ago

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Apr 9, 2025, 8:30 AM EDT - 7 months ago

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Apr 1, 2025, 8:30 AM EDT - 7 months ago

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Mar 4, 2025, 8:30 AM EST - 8 months ago

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Feb 25, 2025, 8:30 AM EST - 8 months ago

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Microbot Medical Closes $13 Million Registered Direct Offering

Feb 11, 2025, 6:15 PM EST - 9 months ago

Microbot Medical Closes $13 Million Registered Direct Offering

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Feb 10, 2025, 8:00 AM EST - 9 months ago

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Closes $8.6 Million Registered Direct Offering

Jan 10, 2025, 10:25 AM EST - 10 months ago

Microbot Medical Closes $8.6 Million Registered Direct Offering

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Jan 7, 2025, 4:15 PM EST - 10 months ago

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Dec 30, 2024, 8:30 AM EST - 10 months ago

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Dec 10, 2024, 10:18 AM EST - 11 months ago

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Oct 15, 2024, 8:38 AM EDT - 1 year ago

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Sep 30, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Aug 22, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Aug 13, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Jul 9, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Jul 8, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Jul 3, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Jun 20, 2024, 8:25 AM EDT - 1 year ago

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Jun 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 4, 2024, 4:20 PM EDT - 1 year ago

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 3, 2024, 12:11 PM EDT - 1 year ago

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

Jun 3, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

Apr 29, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

Microbot Medical Shares Status Following Recent Geopolitical Events

Apr 15, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Shares Status Following Recent Geopolitical Events

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Feb 5, 2024, 7:30 AM EST - 1 year ago

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

Jan 30, 2024, 7:20 AM EST - 1 year ago

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

Jan 18, 2024, 7:20 AM EST - 1 year ago

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Dec 29, 2023, 8:00 AM EST - 1 year ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 5:24 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $MBOT Current Share Price: $2.42 Contracts: $MBOT January 15, 2027 $2 Calls Scale in: $0.98- $1.20 Scale out: $1.52-$1.96 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 2:15 PM
Enter: $MBOT Calls Strike Price: $2 Expiry Date: NOV 21 2025 Buy in Price: $0.30 - $0.40 Sell Price: $0.53 Profit : +75% (Turn every $1 into $1.75) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
Djmorri
Djmorri Oct. 25 at 10:46 AM
$MBOT . Remember, the 12$ pt is the opinion of 1 analyst..only revenue will instill confidence now after the dilution pollution immediately upon fda approval
0 · Reply
aerts2js
aerts2js Oct. 25 at 12:07 AM
$MBOT We are now lower compared to where we were PRIOR to FDA approval. It’s very disappointing. I think we are cooked.
5 · Reply
Reddyrob
Reddyrob Oct. 24 at 9:13 PM
$MBOT by december we will come to know which one MBOT is Good product with good management Or Good product with a bad management Or Bad product with a bad management Or Bad product with a good management. Till then im Bearish
1 · Reply
Daquanladariusblackman2
Daquanladariusblackman2 Oct. 24 at 9:07 PM
$MBOT 100% chance your brain is the size of an amoeba.
0 · Reply
Eddypgil
Eddypgil Oct. 24 at 9:00 PM
$MBOT 50 50 chance it does a reverse split in next two years
0 · Reply
Reddyrob
Reddyrob Oct. 24 at 8:54 PM
$MBOT this company is nowehere where RR is and never will be. RR solves a real world problem of staff shortage and high wage. $MBOT Is in safety business. Both are different vericals. Im sure this product will sell if marketed well. Many of us here only because of FDA, medical devices is not easy to sell first of all. But once customers started using it and ok with it, it cannot be replaced. This stock will fly when sales and customer reviews or results pops everywhere. Im in here with heavy investment and ready to invest more at sub 2 level/by December/at 52wk high. Till then just watch.
0 · Reply
godmode426
godmode426 Oct. 24 at 8:25 PM
$MBOT This company is shady, look at all the names it went through previously and they dilute shares constantly. Never invest in Israel.
2 · Reply
richestbear
richestbear Oct. 24 at 8:11 PM
$MBOT bro…. Sad POS 💩
0 · Reply
BounderRound
BounderRound Oct. 24 at 8:01 PM
$MBOT this has to be the most disappointing ticker to many, who would of thought with FDA approval it would hardly increase and then crash?
3 · Reply
Relee187200
Relee187200 Oct. 24 at 8:00 PM
$MBOT When will this do anything? Damn poc.
0 · Reply
GladysFoster
GladysFoster Oct. 24 at 7:56 PM
$MBOT if it doesn't bounce up from here it could be troublesome
1 · Reply
StStephen72
StStephen72 Oct. 24 at 7:44 PM
$MBOT I'm not at my PC. It's triple witching option today I believe. Someone should check how many $2.50 open calls there are. Pete
0 · Reply
StStephen72
StStephen72 Oct. 24 at 7:42 PM
$MBOT Damnit MNOT. Literally every other ticker in my accounts is up except this one. TGIF. Pete
0 · Reply
MarketGovernor
MarketGovernor Oct. 24 at 6:46 PM
$MBOT obviously this is junk.
1 · Reply
Djmorri
Djmorri Oct. 24 at 6:43 PM
$MBOT. Glad I got out with small profit but pissed at myself because I did not follow my gut and get out when it headed down after approval. This is gonna be Junk for quite awhile I gotta admit
2 · Reply
Reddyrob
Reddyrob Oct. 24 at 5:52 PM
$MBOT almost everyone who learned technical analysis learns stocks bounce from 200DMA, that belief creates more liquidity and a quick fall to dust out. It will bounce but not from here. Market is not linear.
0 · Reply
mstan
mstan Oct. 24 at 5:02 PM
$MBOT re-entry 200DMA 👌🤞
0 · Reply
sldprt
sldprt Oct. 24 at 4:20 PM
$MBOT run down chart, big buyer advantage
0 · Reply
han649
han649 Oct. 24 at 3:48 PM
$MBOT rr is doing really well, hope we can catch up to it , patience its the key, one contract news it’s all I need right now …
0 · Reply
Damiml8
Damiml8 Oct. 24 at 3:30 PM
$MBOT Bought some more today.
0 · Reply